Celyad Oncology News and Activities

Celyad Oncology is a company listed under the stock ticker CYAD (BE).

View the org chart displaying its 13 main executives

Most searched biographies at Celyad Oncology

• Matt Kane, Chief Executive Officer
• Sharon Perez, Non-Executive Director
• Michel Lussier, Director

Create your alert
to follow the executive moves at Celyad Oncology.

Celyad Oncology has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Celyad Oncology

• Newsroom -
• Newsroom -
• Newsroom -
• Newsroom -
• non-regulated information Archives -
• Newsroom -
• Newsroom -
• Newsroom -
• Newsroom -
• inside information Archives -
• View more press releases Close

Social media about Celyad Oncology

• Celyad Oncology on Wikipedia, Google News & Yahoo Finance
• Celyad Oncology on LinkedIn, X (Twitter) & YouTube